167 related articles for article (PubMed ID: 26502806)
1. Mitochondrial dysfunction rather than mtDNA sequence mutation is responsible for the multi-drug resistance of small cell lung cancer.
Ma L; Wang R; Duan H; Nan Y; Wang Q; Jin F
Oncol Rep; 2015 Dec; 34(6):3238-46. PubMed ID: 26502806
[TBL] [Abstract][Full Text] [Related]
2. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
[TBL] [Abstract][Full Text] [Related]
3. Analysis of novel microRNA targets in drug-sensitive and -insensitive small cell lung cancer cell lines.
Ma L; Li P; Wang R; Nan Y; Liu X; Jin F
Oncol Rep; 2016 Mar; 35(3):1611-21. PubMed ID: 26676926
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation.
Li P; Ma L; Zhang Y; Ji F; Jin F
Biomed Pharmacother; 2014 Feb; 68(1):7-12. PubMed ID: 24412084
[TBL] [Abstract][Full Text] [Related]
5. FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide.
Ma J; Li J; Yao X; Lin S; Gu Y; Xu J; Deng Z; Ma W; Zhang H
Oncol Rep; 2017 Apr; 37(4):1935-1942. PubMed ID: 28260065
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
[TBL] [Abstract][Full Text] [Related]
7. Curcumin induces small cell lung cancer NCI-H446 cell apoptosis via the reactive oxygen species-mediated mitochondrial pathway and not the cell death receptor pathway.
Yang CL; Ma YG; Xue YX; Liu YY; Xie H; Qiu GR
DNA Cell Biol; 2012 Feb; 31(2):139-50. PubMed ID: 21711158
[TBL] [Abstract][Full Text] [Related]
8. [Involvement of bcl-2 in multidrug resistance in human small cell lung cancer cell subline H446/DDP].
Ji FY; Qian GS; Qian P; Chen Y; Guo RL; Li SP; Huang GJ
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar; 29(3):156-60. PubMed ID: 16677475
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol promotes the sensitivity of small-cell lung cancer H446 cells to cisplatin by regulating intrinsic apoptosis.
Li W; Shi Y; Wang R; Pan L; Ma L; Jin F
Int J Oncol; 2018 Nov; 53(5):2123-2130. PubMed ID: 30132509
[TBL] [Abstract][Full Text] [Related]
11. Chan-Yu-Bao-Yuan-Tang induces apoptosis in NSCLC and SCLC cell lines via a mitochondria-mediated pathway.
Zhang Y; Zeng F; Liu X; Li Y; Zhou J; Huang Y; Wang Y; Zhou S; Zhu W; Shu E; Zhou G; Chen G
Xenobiotica; 2011 Jul; 41(7):593-602. PubMed ID: 21446835
[TBL] [Abstract][Full Text] [Related]
12. Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.
Fang C; Zhang J; Qi D; Fan X; Luo J; Liu L; Tan Q
PLoS One; 2014; 9(12):e115204. PubMed ID: 25506932
[TBL] [Abstract][Full Text] [Related]
13. Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
Tang C; Luo H; Luo D; Yang H; Zhou X
Oncol Rep; 2018 Feb; 39(2):611-618. PubMed ID: 29207183
[TBL] [Abstract][Full Text] [Related]
14. The human lung cancer drug resistance-related gene BC006151 regulates chemosensitivity in H446/CDDP cells.
Li S; Shi H; Ji F; Wang B; Feng Q; Feng X; Jia Z; Zhao Q; Qian G
Biol Pharm Bull; 2010; 33(8):1285-90. PubMed ID: 20686220
[TBL] [Abstract][Full Text] [Related]
15. YAP1 promotes multidrug resistance of small cell lung cancer by CD74-related signaling pathways.
Song Y; Sun Y; Lei Y; Yang K; Tang R
Cancer Med; 2020 Jan; 9(1):259-268. PubMed ID: 31692299
[TBL] [Abstract][Full Text] [Related]
16. [Role of SPHK1 regulates multi-drug resistance of small cell lung cancer
and its clinical significance].
Yang L; Hu H; Deng Y; Bai Y
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):769-77. PubMed ID: 25404266
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA mutations are involved in the acquisition of cisplatin resistance in human lung cancer A549 cells.
Horibe S; Ishikawa K; Nakada K; Wake M; Takeda N; Tanaka T; Kawauchi S; Sasaki N; Rikitake Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34935060
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer.
Gu T; Ohashi R; Cui R; Tajima K; Yoshioka M; Iwakami S; Sasaki S; Shinohara A; Matsukawa T; Kobayashi J; Inaba Y; Takahashi K
Lung Cancer; 2009 Nov; 66(2):176-83. PubMed ID: 19285749
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer.
Fang S; Zeng X; Zhu W; Tang R; Chao Y; Guo L
Exp Mol Pathol; 2014 Jun; 96(3):438-44. PubMed ID: 24769353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
